glp 1 heart benefits GLP-1 and GIP–GLP-1 therapies in diabetes and obesity | Gustavo Monnerat posted on the topic Benefits of Semaglutide GLP-1 Injections

The Myers Cocktail has a deep history of treating chronic conditions and nutrient deficiencies

- The Next Step in Weight Management Zepbound, a GLP-1 drug, has recently gained FDA approval for weight loss

In addition, it regulates glucose transport and reduces the chance of biochemical conversion into fat that is deposited subcutaneously

The FDA approved tirzepatide in May 2022 under the brand name Mounjaro for type 2 diabetes management, and in November 2023 under the brand name Zepbound for chronic weight management in adults meeting specific BMI criteria

The tirzepatide vial Compounded tirzepatide comes in several common sizes